Enveric Biosciences (ENVB) stock plummeted 13% pre-market, facing its worst drop since January. The company priced a $13.9 million offering to sell 2.2 million shares at a discount. Proceeds of $5 million will fund product development and working capital. Warrants could add another $8.9 million.